Mutations in the CHEK2 gene can lead to a loss of function, impairing the cell's ability to respond to DNA damage effectively. This can result in increased susceptibility to cancer, particularly breast, prostate, and colorectal cancers. In histological studies, the identification of CHEK2 mutations can provide insights into the pathogenesis of these cancers and inform treatment strategies.
